April 2014

NHS England to fund hepatitis C drug Sovaldi

February 2014

B-MS oral HCV combo gets FDA breakthrough status

January 2014

Gilead's HCV drug Sovaldi gets Europe OK

December 2013

AbbVie hep C drug cures 96% of patients in 12 weeks

Gilead's HCV drug gets green light in USA

November 2013

Thumbs-up for J&J drugs Olysio and Invokana

BI HCV drug faldaprevir shows promise

October 2013

Vertex cuts workforce by 15% as HCV drug declines

Gilead gets FDA panel backing for hep C pill

FDA panel backs J&J/Medivir's hepatitis C drug

Merck & Co hep C combo designated as breakthrough

May 2013

AbbVie hep C combo designated as breakthrough therapy